Senores Pharmaceuticals Limited — Board Meeting, 28-03-2026: Outcome of Board Meeting
28-03-2026 | 12:52 pm
28-03-2026 | 12:52 pm
Senores Pharma's board approved allotting 11.7 lakh preferential warrants to promoter/promoter group at ₹812 each. This totals ₹95.004 Cr, with ₹23.751 Cr received upfront. Warrants are convertible into equity shares within 18 months.
No comments yet. Be the first to comment!
